发明授权
US09023802B2 HLA-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof 有权
衍生自前列腺相关抗原分子的HLA结合肽及其使用方法

HLA-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
摘要:
Methods and compositions for immunotherapeutic treatment of prostate cancer are disclosed. Patients are treated with compositions comprising HLA-binding peptides derived from prostate-associated antigenic molecules, either with or without immunological adjuvants.
信息查询
0/0